D.A. Davidson & Co. Ionis Pharmaceuticals Inc Call Options Transaction History
D.A. Davidson & Co.
- $15.1 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IONS
# of Institutions
450Shares Held
150MCall Options Held
1.91MPut Options Held
808K-
Dld Asset Management, LP New York, NY25MShares$1.81 Billion7.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.19 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.16 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$922 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$748 Million0.01% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.3B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...